Airbus and Kratos (KTOS) collaborate on Valkyrie combat drones with European mission systems for Germany’s Air Force, targeting 2029 deployment with AI integration.
Browsing: Stocks
SentinelOne (S) stock fell 4% after strong Q4 results, as FY2027 revenue guidance of $1.195B-$1.205B disappointed despite crossing $1B revenue milestone.
Carvana (CVNA) shares jumped 3% after the board approved a historic 5-for-1 stock split. Shareholders vote May 5. Trading starts May 7 if approved.
Carvana (CVNA) shares gained 3% after the board approved its inaugural 5-for-1 stock split, awaiting shareholder approval at the May 5 annual meeting.
Apple (AAPL) slashes China App Store fees to 25% from 30% after regulatory talks. Small developers see rates drop to 12%. Stock up 0.3% in premarket.
Bumble (BMBL) stock rocketed 34% after CEO Whitney Wolfe Herd revealed AI dating assistant ‘Bee’ on the Q4 earnings call—its largest gain since 2022.
Core PCE inflation hit 3.1% in January 2026, exceeding the Fed’s 2% target. Markets anticipate rates will stay at 3.5%–3.75% at the upcoming meeting.
Circle Internet (CRCL) stock gains analyst upgrades as USDC volume overtakes Tether. Price targets range from $85 to $190 amid 49% YTD rally.
Microsoft (MSFT) stock has fallen 28% to its cheapest valuation in over 10 years despite 39% Azure growth and a massive OpenAI stake worth $200B+.
Robinhood (HOOD) fell 2% after-hours on February data showing equity trading down 14% from January, though crypto volume surged 74% year-over-year.
Jim Cramer advises buying Bitcoin instead of Coinbase (COIN) stock. Q4 earnings miss expectations, insiders dump $84M in shares, analysts cut targets.
US stock futures rise as oil pulls back from $100, Bitcoin surges past $72K, and Iran conflict alters Fed rate expectations. Latest market analysis.
Immutep (IMMP) stock plunged 80% after halting its Phase III lung cancer trial. Analysts downgrade shares as TACTI-004 study fails efficacy review.
Acurx Pharmaceuticals (ACXP) stock jumped 218% after announcing a clinical trial for ibezapolstat, targeting recurrent C. difficile infection.
Adobe falls 7.5% on CEO departure, Ulta Beauty drops 8.4% on cautious outlook, and SentinelOne slides on disappointing guidance. Friday market movers analyzed.